May 16, 2018

Wednesday, May 16

12:30 – 1:30

Registration and Networking

1:30 – 1:35

Welcome and Opening Remarks

Bob Buderi, Xconomy

1:35 – 1:55

Opening Keynote

Eric Lander, Broad Institute of MIT and Harvard

1:55 – 2:25

Setting the Price, and Value, of the first U.S. Gene Therapy

Dan Ollendorf, Institute for Clinical and Economic Review
John Furey, Spark Therapeutics
Michael Sherman, Harvard Pilgrim Health Care
Michael Pace, ICON (moderator)

2:30 – 3:00

Future Founders: Opening Doors for Young Biotech Entrepreneurs

Anna Greka, Goldfinch Biopharma; Broad Institute of MIT and Harvard
Amy Schulman, Lyndra; Polaris Partners
Cigall Kodach, Foghorn Therapeutics; Broad Institute of MIT and Harvard
Teresa Lavoie, Fish and Richardson (moderator)

3:00 – 3:30

RNAi: From Lab Experiment to FDA Review

Craig Mello, University of Massachusetts Medical School, RNA Therapeutics Institute
Barry Greene, Alnylam Pharmaceuticals

3:30 – 4:00

Networking Break

4:00 – 4:30

CAR-T: The Early Launch and What’s to Come

Jeff Engleman, Novartis Institutes for BioMedical Research
Caron Jacobson, Dana-Farber Cancer Institute
Andreas Klein, Tufts Medical Center

4:30 – 4:50

To be determined

Stephen Hoge, Moderna

4:50 – 5:20

Gene Editing’s Next Frontier: Human Trials

Feng Zhang, Broad Institute of MIT and Harvard
Kara Miller, WGBH (moderator)

5:20 – 6:30

Networking Reception

Please note that this schedule is subject to change.